Oppenheimer Asset Management Inc. raised its position in Humana Inc. (NYSE:HUM - Free Report) by 197.8% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 9,835 shares of the insurance provider's stock after buying an additional 6,533 shares during the quarter. Oppenheimer Asset Management Inc.'s holdings in Humana were worth $2,602,000 at the end of the most recent reporting period.
A number of other institutional investors have also recently made changes to their positions in the company. LFA Lugano Financial Advisors SA grew its stake in Humana by 56.3% in the 4th quarter. LFA Lugano Financial Advisors SA now owns 125 shares of the insurance provider's stock valued at $32,000 after buying an additional 45 shares in the last quarter. OFI Invest Asset Management bought a new position in shares of Humana in the fourth quarter worth $33,000. Riverview Trust Co purchased a new position in shares of Humana in the first quarter valued at $34,000. Garde Capital Inc. purchased a new position in shares of Humana in the first quarter valued at $36,000. Finally, Transce3nd LLC bought a new stake in shares of Humana during the 4th quarter valued at $38,000. Hedge funds and other institutional investors own 92.38% of the company's stock.
Wall Street Analyst Weigh In
Several brokerages have commented on HUM. Guggenheim started coverage on Humana in a research note on Wednesday, April 9th. They issued a "buy" rating and a $326.00 target price for the company. Robert W. Baird increased their price target on shares of Humana from $270.00 to $300.00 and gave the stock a "neutral" rating in a report on Tuesday, April 15th. Cantor Fitzgerald restated a "neutral" rating and issued a $290.00 price objective on shares of Humana in a research report on Thursday, May 1st. Raymond James Financial raised shares of Humana from a "market perform" rating to an "outperform" rating and set a $315.00 price objective for the company in a research note on Thursday, May 1st. Finally, Wall Street Zen cut shares of Humana from a "buy" rating to a "hold" rating in a research note on Saturday, June 14th. Seventeen investment analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company's stock. According to data from MarketBeat.com, Humana has an average rating of "Hold" and a consensus target price of $280.76.
Check Out Our Latest Stock Report on HUM
Humana Price Performance
Shares of Humana stock traded up $1.92 during trading on Friday, hitting $241.82. 1,755,323 shares of the stock traded hands, compared to its average volume of 1,817,394. The stock has a market cap of $29.18 billion, a price-to-earnings ratio of 17.10, a PEG ratio of 1.80 and a beta of 0.43. The company has a quick ratio of 1.91, a current ratio of 1.91 and a debt-to-equity ratio of 0.71. Humana Inc. has a 52 week low of $212.45 and a 52 week high of $406.46. The firm's fifty day moving average is $242.39 and its 200-day moving average is $259.73.
Humana (NYSE:HUM - Get Free Report) last issued its earnings results on Wednesday, April 30th. The insurance provider reported $11.58 earnings per share (EPS) for the quarter, topping the consensus estimate of $10.07 by $1.51. Humana had a return on equity of 14.47% and a net margin of 1.42%. The business had revenue of $32.11 billion during the quarter, compared to analyst estimates of $32 billion. During the same quarter in the prior year, the firm earned $7.23 earnings per share. Humana's revenue for the quarter was up 8.4% on a year-over-year basis. Research analysts expect that Humana Inc. will post 16.47 EPS for the current fiscal year.
Humana Announces Dividend
The firm also recently announced a quarterly dividend, which will be paid on Friday, July 25th. Investors of record on Friday, June 27th will be issued a dividend of $0.885 per share. This represents a $3.54 annualized dividend and a dividend yield of 1.46%. The ex-dividend date of this dividend is Friday, June 27th. Humana's dividend payout ratio is currently 25.04%.
About Humana
(
Free Report)
Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.
Featured Stories
Before you consider Humana, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Humana wasn't on the list.
While Humana currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
